Halt Rosiglitazone (Avandia) Trial

Links shared publicly online about this topic.

  • 1,023
    total visits

Halt Rosiglitazone (Avandia) Trial

citizen.org

Halt Rosiglitazone (Avandia) Trial

View full resource at citizen.org

Tags: Diabetes Type 2 Medication, Diabetes Medication, FDA, Avandia, Avandamet, Avandaryl

  • Share

Most Recently Shared on July 14, 2010 at 2:23 pm By:

theheartorg Shelley Wood

#Avandia - Dr Sidney Wolfe (Public Citizen) addresses OPH. PC's letter to FDA here: http://bit.ly/cBqWx3. Wolfe not a big Rosi fan.

2 years ago...

WCIR: Rosiglitazone Not Linked to Heart Hazard in BARI 2D (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “LOS ANGELES (MedPage Today) -- After further data review, the insulin-sensitizing agent rosiglitazone (Avandia) appears to have reduced rates of cardiovascular events in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial, researchers said here.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on November 8, 2010 at 6:49 pm By:

MedicalFeed MedicalFeed Health News Feed

WCIR: Rosiglitazone Not Linked to Heart Hazard in BARI 2D (CME/CE): LOS ANGELES (MedPage Today) -- After further d... http://bit.ly/dblQgf

1 year ago...

FDA Says Rosiglitazone Can Stay, But EMA Pulls the Plug - QualityPoint Technologies

qualitypointtech.net — “After months of deliberations, the FDA has opted to allow GlaxoSmithKline to continue to market Avandia for the treatment of type 2 diabetes, despite its much ballyhooed cardiovascular risk profile. It also opted to stop the TIDE trial, pending a rereview of the RECORD trial. But in sharp contrast, the EMA has ordered the withdrawal of all rosiglitazone-containing products. HeartwireView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on September 23, 2010 at 6:36 pm By:

MedicalFeed MedicalFeed Health News Feed

FDA Says Rosiglitazone Can Stay, But EMA Pulls the Plug: After months of deliberations, the FDA has opted to allow... http://bit.ly/chvu9Q

2 years ago...

FDA Orders Halt on Avandia Trial Enrollment :: Diabetes Self-Management

diabetesselfmanagement.com — “The US Food and Drug Administration has ordered GlaxoSmithKline (GSK), maker of the controversial diabetes drug Avandia, to halt enrollment in the TIDE (Thiazolidinedione Intervention With Vitamin D Evaluation) trial, designed to compare the cardiovascular safety of Avandia to that of the diabetes drug Actos in people with Type 2...View full resource at diabetesselfmanagement.com

  • View Related
  • Share

Most Recently Shared on July 23, 2010 at 7:51 pm By:

ManageDiabetes Diabetes Self-Mgmt Health Site

#diabetes The FDA has ordered a halt on enrollment in the Avandia TIDE trial. http://bit.ly/cUTTxL

2 years ago...

Statement On FDA Placing Hold On TIDE Safety Trial

medicalnewstoday.com — “The U.S. Food and Drug Administration (FDA) informed GlaxoSmithKline (GSK), the manufacturer of rosiglitazone (Avandia), that the postmarketing safety trial known as TIDE has been placed on partiaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 23, 2010 at 3:17 pm By:

sstrumello Scott Strumello Patient Expert

Statement On FDA Placing Hold On Avandia TIDE Safety Trial http://bit.ly/aWToZ9

2 years ago...

Statement on FDA Placing Hold on TIDE Safety Trial

endo-society.org — “The U.S. Food and Drug Administration (FDA) today informed GlaxoSmithKline (GSK), the manufacturer of rosiglitazone (Avandia), that the postmarketing safety trial known as TIDE has been placed on partial clinical hold...View full resource at endo-society.org

  • View Related
  • Share

Most Recently Shared on July 23, 2010 at 1:04 pm By:

PharmaGossip: PharmaTimes | EU needs more time to review Avandia as FDA halts TIDE trial

pharmagossip.blogspot.com — “PharmaGossip: PharmaTimes | EU needs more time to review Avandia as FDA halts TIDE trialView full resource at pharmagossip.blogspot.com

  • View Related
  • Share

Most Recently Shared on July 23, 2010 at 7:24 am By:

pharmagossip Jack Friday - PharmaGossip Health Blog

PharmaGossip: PharmaTimes | EU needs more time to review Avandia as FDA halts TIDE trial: The European Medicines ... http://bit.ly/cZ2Srx

2 years ago...

PharmaTimes | EU needs more time to review Avandia as FDA halts TIDE trial - Jack's posterous

pharmagossip.posterous.com — “PharmaTimes | EU needs more time to review Avandia as FDA halts TIDE trial - Jack's posterousView full resource at pharmagossip.posterous.com

  • View Related
  • Share

Most Recently Shared on July 23, 2010 at 7:24 am By:

pharmagossip Jack Friday - PharmaGossip Health Blog

PharmaTimes | EU needs more time to review Avandia as FDA halts TIDE trial http://post.ly/oOlY

2 years ago...

A.M. Vitals: FDA Halts New Enrollment in Avandia-Actos Trial - Health Blog - WSJ

blogs.wsj.com — “Also: surpluses at nonprofit insurers; tainted heparin investigation; new rules on external review of denied insurance claims.View full resource at blogs.wsj.com

  • View Related
  • Share

Most Recently Shared on July 22, 2010 at 12:52 pm By:

WSJHealthBlog WSJ Health Blog Health News

A.M. Vitals: FDA Halts New Enrollment in Avandia-Actos Trial http://on.wsj.com/clYxWT

2 years ago...

Avandia maker ordered to halt recruiting for trials - The Boston Globe

healthcare.tweetmeme.com — “All the news on healthcareView full resource at healthcare.tweetmeme.com

  • View Related
  • Share

Most Recently Shared on July 22, 2010 at 6:43 am By:

TM_Healthcare Healthcare TweetMeme Health Social Media

Avandia maker ordered to halt recruiting for trials - The Boston Globe http://retwt.me/1NXKb (via @prasadgurjar555)

2 years ago...

FDA orders halt in enrollment in clinical trial for diabetes drug Avandia - White Coat Notes - Boston.com

healthcare.tweetmeme.com — “All the news on healthcareView full resource at healthcare.tweetmeme.com

  • View Related
  • Share

Most Recently Shared on July 22, 2010 at 1:14 am By:

TM_Healthcare Healthcare TweetMeme Health Social Media

FDA orders halt in enrollment in clinical trial for diabetes drug Avandia - .. http://retwt.me/1NXAA (via @BostonMedJobs)

2 years ago...

FDA orders halt in enrollment in clinical trial for diabetes drug Avandia - White Coat Notes - Boston.com

healthcare.tweetmeme.com — “All the news on healthcareView full resource at healthcare.tweetmeme.com

  • View Related
  • Share

Most Recently Shared on July 22, 2010 at 12:59 am By:

TM_Healthcare Healthcare TweetMeme Health Social Media

FDA orders halt in enrollment in clinical trial for diabetes drug Avandia - Wh.. http://retwt.me/1NXzX (via @GlobeHealth)

2 years ago...

FDA halts new enrollment in Glaxo's Avandia trial http://link.reuters.com/fap78m

reuters.com — “FDA halts new enrollment in Glaxo's Avandia trial http://link.reuters.com/fap78mView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on July 21, 2010 at 5:21 pm By:

FDA will consider halting TIDE, based on advisory committee's input

theheart.org — “Responding to a report issued by the Senate Finance Committee, FDA commissioner Margaret Hamburg says the agency is convening a joint advisory committee meeting to get expert opinion on all the recent evidence questioning rosiglitazone's cardiovascular safety profile—if need be, the agency could stop the much-debated TIDE trial.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on July 14, 2010 at 1:20 pm By:

theheartorg Shelley Wood Cardiology

#Avandia IoM's Steve Goodman and Ruth Faden present their take on ethics of a trial like TIDE, something FDA asked for. http://bit.ly/cE7Pp3

2 years ago...

Reanalysis of rosiglitazone meta-analysis raises questions

theheart.org — “A new analysis of the same 42 trials, but using a number of different statistical methods to account for all the zero events, found no significant increase in either MI or CV death and highlights flaws in the original study. In response, Nissen counters that the report is now neither useful nor relevant in the wake of the FDA hearing. The FDA panel chair says the whole saga highlights the need for drug-approval reform. (Diamond G et al. Ann Intern Med; published online before print August 6, 200View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on July 13, 2010 at 10:19 pm By:

theheartorg Shelley Wood Cardiology

#Avandia - Last minute question Kaul to Nissen! Recall Kaul co-authored rosiglitazone critique of Nissen's 2007 paper: http://bit.ly/dwD8yi

2 years ago...

Advertisement